SI2094116T1 - Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba - Google Patents

Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba

Info

Publication number
SI2094116T1
SI2094116T1 SI200730321T SI200730321T SI2094116T1 SI 2094116 T1 SI2094116 T1 SI 2094116T1 SI 200730321 T SI200730321 T SI 200730321T SI 200730321 T SI200730321 T SI 200730321T SI 2094116 T1 SI2094116 T1 SI 2094116T1
Authority
SI
Slovenia
Prior art keywords
solid
aqueous alkaline
alkaline preparation
production
creatine
Prior art date
Application number
SI200730321T
Other languages
English (en)
Slovenian (sl)
Inventor
Thomas Gastner
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38980980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2094116(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Publication of SI2094116T1 publication Critical patent/SI2094116T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SI200730321T 2006-10-28 2007-10-26 Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba SI2094116T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006050931A DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
EP07819368A EP2094116B1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung
PCT/EP2007/009324 WO2008052712A1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
SI2094116T1 true SI2094116T1 (sl) 2010-09-30

Family

ID=38980980

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730321T SI2094116T1 (sl) 2006-10-28 2007-10-26 Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba

Country Status (11)

Country Link
US (1) US20100056633A1 (enExample)
EP (1) EP2094116B1 (enExample)
JP (1) JP5590889B2 (enExample)
AT (1) ATE468030T1 (enExample)
CA (1) CA2667667C (enExample)
DE (2) DE102006050931A1 (enExample)
DK (1) DK2094116T3 (enExample)
ES (1) ES2341910T3 (enExample)
PL (1) PL2094116T3 (enExample)
SI (1) SI2094116T1 (enExample)
WO (1) WO2008052712A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
EP2653161B1 (en) 2008-12-30 2015-10-07 Hill's Pet Nutrition, Inc. Use of lipoic acid for maintaining or increasing bone mineral density in companion animals
PL2416770T3 (pl) 2009-04-06 2017-06-30 Crearene Ltd. Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny
US10449157B2 (en) 2013-06-12 2019-10-22 Anabio Technologies Limited Process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
JP6991445B2 (ja) * 2016-09-06 2022-02-03 地方独立行政法人青森県産業技術センター アルギニンを豊富に含有する多糖

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements
US5318784A (en) * 1992-09-09 1994-06-07 Amurol Products Company Pourable chewing gum and confection composition
US5908864A (en) * 1998-05-28 1999-06-01 Dymatize Enterprises Creatine gel
DE19830768A1 (de) * 1998-07-09 2000-01-13 Sueddeutsche Kalkstickstoff Kreatin-enthaltende Formulierung und Verfahren zu deren Herstellung
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6114379A (en) * 1999-07-07 2000-09-05 Albion Laboratories, Inc. Bioavailable chelates of creatine and essential metals
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6399661B1 (en) * 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
EP1363509B1 (en) * 2001-03-02 2006-10-11 The Howard Foundation Compositions containing creatine and creatinine
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
GB0323240D0 (en) * 2003-10-03 2003-11-05 Golini Jeffrey M Creatine composition and use
SI1758463T1 (sl) * 2004-06-09 2008-08-31 Alzchem Trostberg Gmbh Gvanidino ocetna kislina kot dodatek Ĺľivalski hrani
US20080003208A1 (en) * 2006-05-11 2008-01-03 Avicena Froup, Inc. Creatine-ligand compounds and methods of use thereof

Also Published As

Publication number Publication date
DE102006050931A1 (de) 2008-04-30
JP2010508249A (ja) 2010-03-18
CA2667667C (en) 2014-09-09
JP5590889B2 (ja) 2014-09-17
PL2094116T3 (pl) 2010-10-29
ES2341910T3 (es) 2010-06-29
EP2094116A1 (de) 2009-09-02
CA2667667A1 (en) 2008-05-08
ATE468030T1 (de) 2010-06-15
EP2094116B1 (de) 2010-05-19
DK2094116T3 (da) 2010-09-06
DE502007003888D1 (de) 2010-07-01
US20100056633A1 (en) 2010-03-04
WO2008052712A1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
PL2094116T3 (pl) Stały lub wodny alkaliczny preparat obejmujący składnik kreatynowy, sposób jego wytwarzania i jego zastosowanie
NZ597260A (en) Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone
UA105078C2 (uk) Фармацевтична композиція, яка містить тетрагідрофолієву кислоту
WO2008003958A3 (en) Fused pyrimido compounds
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
ZA200704430B (en) Syntheis and uses of 2-oxo-4-methylthiobutyric acid, its salts and its derivatives
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
MX2009003065A (es) Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion.
IL208183A0 (en) Argatroban formulation
GB201200192D0 (en) Methotrexate composition
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
GEP20135940B (en) Solid preparations
NZ593787A (en) Lyophilised dabigatran
GEP20125582B (en) Extended-release composition comprising somatostatin derivative in microparticles
ATE461276T1 (de) Enzymstabilisierung
GEP20105031B (en) Stable emulsion composition
WO2011051916A3 (en) Stabilized protein formulations and use thereof
EP1832622A3 (en) Method for producing an arsenic-selective resin
MY161912A (en) Generally spherical barium carbonate particles and method for producing generally spherical barium carbonate particles
WO2007138462A3 (en) Aqueous oral formulations of risperidone
NZ591213A (en) A formulation of canfosfamide consisting of 50 mg/mL canfosfamide hydrochloride in aqueous sodium citrate buffer
WO2007018585A3 (en) Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
UA93355C2 (ru) Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения
EP1767090A4 (en) CLATHRATE COMPOUND, METHOD FOR CONTROLLING THE CONCENTRATION OF AQUEOUS SOLUTION IN AN AGROCHEMICAL ACTIVE INGREDIENT, AND AGROCHEMICAL PREPARATION
WO2010071321A3 (ko) 메트포르민 및 α-글리코시다제 억제제를 포함하는 경구 제제 및 그 제조방법